During the past decade, Prisma Health Cancer Institute - Faris conducted 190 clinical trials. In the 10-year time frame, 190 clinical trials started and 140 clinical trials were completed, i.e. on average, 73.7% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 89 clinical trials were completed. i.e. 134.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Faris" #1 sponsor was "National Cancer Institute (NCI)" with 109 trials, followed by "SWOG Cancer Research Network" with 58 trials sponsored, "Alliance for Clinical Trials in Oncology" with 57 trials sponsored, "NRG Oncology" with 23 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Faris" #1 collaborator was "National Cancer Institute (NCI)" with 200 trials as a collaborator, "NRG Oncology" with 38 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Faris" are "Breast Cancer" (21 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Faris" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Faris" are "Drug" (232 trials), "Other" (207 trials), "Biological" (100 trials), "Radiation" (67 trials) and "Procedure" (64 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (92 trials), "Quality-of-Life Assessment" (77 trials), "Questionnaire Administration" (57 trials), "Cisplatin" (31 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Faris" are 243 trials for "All" genders, 61 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Faris". undefined are not yet recruiting, 67 are recruiting, 142 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in Prisma Health Cancer Institute - Faris, 6 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Faris, 10 "Phase 1" clinical trials were conducted, 128 "Phase 2" clinical trials and 161 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 20 trials that are defined as “Not Applicable".